News
Sarepta will resume gene therapy shipments
Digest more
Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...
Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys for ...
Sarepta Therapeutics stock is surging nearly 50% after the Food and Drug Administration told the company it can [lift a voluntary pause on shipments of Elevidys](http ...
Sarepta Therapeutics now trades at book value with strong cash and cost-cutting plans, while ELEVIDYS may regain broader use.
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $100 million milestone payment from ...
The selloff came after the U.S. Food and Drug Administration said late Friday that it was probing the death of an 8-year-old ...
Explore more
Some results have been hidden because they may be inaccessible to you
Show inaccessible results